News | November 08, 2007

Bayer HealthCare Pharmaceuticals Signs Three-Year Renewal Agreement for MR Contrast Media

November 9, 2007 - Bayer HealthCare Pharmaceuticals announced that the company has been awarded a three-year contract renewal by HealthTrust Purchasing Group, LP (HealthTrust), to make Magnevist (gadopentetate dimeglumine) Injection available to members of the HealthTrust network.

Magnevist is used to enhance certain MRI procedures, and reportedly has the broadest range of FDA approved indications of any MRI contrast agent for adult and pediatric patients.

For the past seven years, Berlex, Inc. has provided the HealthTrust membership with MRI contrast media. Berlex is now part of Bayer HealthCare Pharmaceuticals as a result of Bayer's acquisition of Berlex's affiliate, Schering AG Germany. The new agreement calls for Bayer HealthCare Pharmaceuticals to continue as a provider of MRI contrast media to HealthTrust for the next three years.

For more information: www.pharma.bayer.com

Related Content

ACR Offers Revised Contrast Media in Imaging Manual
News | Contrast Media | July 17, 2017
The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of...
Sponsored Content | Case Study | Contrast Media Injectors | April 13, 2017
The volume of computed tomography (CT) imaging exams continues to grow in the United States,[2] adding pressure to...
contrast media
Feature | Contrast Media Injectors | March 02, 2017 | By Jeff Zagoudis
With medical imaging use on the rise, contrast media use is expected to grow as well, according to a May 2016 report...
contrast media
News | Contrast Media | December 09, 2016
At the 2016 Annual Meeting of the Radiological Society of North America (RSNA 2016), Bracco Diagnostics Inc. showcased...
GlobalData, contrast media injectors market,
News | Contrast Media Injectors | May 03, 2016
The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 billion by...
CTA, CT, contrast media injector, contrast injector, EmpowerCTA

Bracco's new EmpowerCTA+, designed for cardiac CT angiography exams.

Feature | Contrast Media Injectors | April 29, 2016 | Jeff Zagoudis
The biggest trend in contrast media injector technology today is one seen throughout all of healthcare — doing more...
Guerbet, OptiOne single-head contrast delivery system, FDA 510k clearance
Technology | Contrast Media Injectors | February 16, 2016
February 16, 2016 — Guerbet announced that it has received 510K clearance from the U.S.
News | Contrast Media | November 29, 2015
November 29, 2015 — Guerbet announced that it has completed its acquisition of the "contrast media and delivery syste
Galt Medical, Health Line International Corp., Nexus CT Midline Catheter with MST Insertion Kit

Image courtesy of Galt Medical

Technology | Contrast Media Injectors | October 01, 2015
October 1, 2015 — Galt Medical has partnered with Health Line International Corp.
Technology | March 06, 2015
Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an...
Overlay Init